Sarepta Therapeutics, Inc. - SRPT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 08, 2026 | Chief Financial Officer | F | D | 13,272.0 | 22.22 | 294,903.84 | 121,792.0 | View | |
| Sep 08, 2026 | Chief Operating Officer | F | D | 24,799.0 | 22.22 | 551,033.78 | 177,184.0 | View | |
| Sep 08, 2026 | EVP, General Counsel | F | D | 22,025.0 | 22.22 | 489,395.5 | 115,519.0 | View | |
| Sep 08, 2026 | President, R&D and Tech Ops | F | D | 21,423.0 | 22.22 | 476,019.06 | 203,900.0 | View | |
| Jul 29, 2026 | Chief Executive Officer | A | A | 2,224,342.0 | 0.0 | 0.0 | 2,224,342.0 | View | |
| Jul 29, 2026 | Chief Executive Officer | A | A | 756,104.0 | — | — | 756,104.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 25,138.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 18,640.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 42,098.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 214,357.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 22,100.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 48,407.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 27,535.0 | View | |
| Jun 05, 2026 | — | A | A | 16,875.0 | — | — | 2,983,542.0 | View |